EDSA is trading at $2.30, up 7.48% in pre-market.
🟢 Edesa Biotech Inc is trading 7.48% up in pre-market
Edesa Biotech Inc
Related News
EDSA
Edesa Biotech Receives EU Orphan Drug Designation for Paridiprubart in ARDS Treatment
EDSA
🟢 Edesa Biotech is trading 51.87% up today after licensing ARDS drug rights to Kyorin
EDSA
Edesa Biotech Signs Japan Licensing Deal with Kyorin for ARDS Drug Paridiprubart
EDSA
Edesa's $12 Million KYORIN Deal Validates Its Lung Drug — But Can a Micro-Cap Turn Milestones Into Real Market Value?
EDSA